Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu tisková chyba
PubMed
33948021
DOI
10.1038/s41591-021-01367-w
PII: 10.1038/s41591-021-01367-w
Knihovny.cz E-zdroje
- Publikační typ
- tisková chyba MeSH
Center for Hematologic Malignancies Memorial Sloan Kettering Cancer Center New York NY USA
Chang Gung Memorial Hospital at Linkou Chang Gung University Taoyuan City Taiwan
CIBERONC Instituto de Salud Carlos 3 Madrid Spain
Clinics of Hematology and Medical Oncology University Medical Center Göttingen Germany
Department of Biomedical and Neuromotor Sciences University of Bologna Bologna Italy
Department of Biomedical Sciences Humanitas University Milan Italy
Department of Data Sciences Dana Farber Cancer Institute Boston MA USA
Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York NY USA
Department of Genomics Institute of Hematology and Blood Transfusion Prague Czech Republic
Department of Health Sciences University of York York UK
Department of Hematology and Genetics Unit University Hospital La Fe Valencia Spain
Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan
Department of Hematology Atomic Bomb Disease Institute Nagasaki University Nagasaki Japan
Department of Hematology Chugoku Central Hospital Fukuyama Japan
Department of Hematology Democritus University of Thrace Medical School Alexandroupolis Greece
Department of Hematology Faculty of Medicine University of Tsukuba Tsukuba Japan
Department of Hematology Gifu Municipal Hospital Gifu Japan
Department of Hematology Gifu University Graduate School of Medicine Gifu Japan
Department of Hematology Hôpital St Louis and Paris University Paris France
Department of Hematology Hospital Universitario y Politécnico La Fe Valencia Spain
Department of Hematology IRCCS Fondazione Policlinico S Matteo Pavia Italy
Department of Hematology Kobe City Medical Center General Hospital Kobe Japan
Department of Hematology VU University Medical Center Amsterdam Amsterdam the Netherlands
Department of Medicine Memorial Sloan Kettering Cancer Center New York NY USA
Department of Molecular Medicine University of Pavia Pavia Italy
Department of Pathology and Tumor Biology Kyoto University Kyoto Japan
Department of Pathology Massachusetts General Hospital Boston MA USA
Department of Pathology Memorial Sloan Kettering Cancer Center New York NY USA
Drug Research and Development Center Federal University of Ceara Ceara Brazil
Haematological Malignancy Diagnostic Service St James's University Hospital Leeds UK
Humanitas Clinical and Research Center IRCCS Humanitas Cancer Center Milan Italy
Institute of Hematology S Orsola Malpighi University Hospital Bologna Italy
Integrated Genomics Operation Memorial Sloan Kettering Cancer Center New York NY USA
Japanese Data Center for Hematopoietic Cell Transplantation Nagoya Japan
Laboratory Hematology Department LABGK Radboud University Medical Centre Nijmegen the Netherlands
MDS Group Institut de Recerca Contra la Leucèmia Josep Carreras Barcelona Spain
MDS Unit Hematology AOU Careggi University of Florence Florence Italy
Oncology Hematology Center Hospital Israelita Albert Einstein São Paulo Brazil
Radcliffe Department of Medicine University of Oxford and Oxford BRC Haematology Theme Oxford UK
Stanford University Cancer Institute Stanford CA USA
Citace poskytuje Crossref.org